相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Signaling Pathways as Specific Pharmacologic Targets for Neuroendocrine Tumor Therapy: RET, PI3K, MEK, Growth Factors, and Notch
Yvette Carter et al.
NEUROENDOCRINOLOGY (2013)
Pharmacological inhibition of GSK3 attenuates DNA damage-induced apoptosis via reduction of p53 mitochondrial translocation and Bax oligomerization in neuroblastoma SH-SY5Y CELLS
Patchara Ngok-Ngam et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2013)
Notch pathway activation induces neuroblastoma tumor cell growth arrest
Peter E. Zage et al.
PEDIATRIC BLOOD & CANCER (2012)
Novel Agents Targeting the IGF-1R/PI3K Pathway Impair Cell Proliferation and Survival in Subsets of Medulloblastoma and Neuroblastoma
Anna Wojtalla et al.
PLOS ONE (2012)
GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line
Amy Dickey et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
The emerging mechanisms of isoform-specific PI3K signalling
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway
Scott N. Pinchot et al.
AMERICAN JOURNAL OF SURGERY (2009)
Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
Jia Luo
CANCER LETTERS (2009)
A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286
Javier G. Pizarro et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
The insulin-like growth factor system and sarcomas
Bart Rikhof et al.
JOURNAL OF PATHOLOGY (2009)
Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3β
Joel T. Adler et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells
David Yu Greenblatt et al.
ANNALS OF SURGERY (2008)
Maintenance of constitutive IκB kinase activity by glycogen synthase kinase-3α/β in pancreatic cancer
Willie Wilson et al.
CANCER RESEARCH (2008)
Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs
Ana Martinez
MEDICINAL RESEARCH REVIEWS (2008)
Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells
Muthusamy Kunnimalaiyaan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells
Muthusamy Kunnimalaiyaan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Glycogen synthase kinase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cancer cells
AV Ougolkov et al.
CANCER RESEARCH (2005)
GSK3 inhibitors: Development and therapeutic potential
P Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Neuroblastoma in adolescents and adults: The memorial Sloan-Kettering experience
BH Kushner et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2003)
Paediatric embryonic brain tumours: biological and clinical relevance of molecular genetic abnormalities
R Gilbertson
EUROPEAN JOURNAL OF CANCER (2002)
The developmental biology of brain tumors
R Wechsler-Reya et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
分享论文
